Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,123 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $188.91 | 2 | $0 (2023) |
| Relievant Medsystems, Inc. | $156.16 | 2 | $0 (2022) |
| Boston Scientific Corporation | $150.01 | 2 | $0 (2024) |
| MML US, Inc. | $137.51 | 1 | $0 (2022) |
| Augmenix, Inc. | $137.26 | 1 | $0 (2018) |
| Janssen Scientific Affairs, LLC | $133.47 | 2 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $105.21 | 1 | $0 (2017) |
| Astellas Pharma US Inc | $100.00 | 1 | $0 (2017) |
| Medtronic Vascular, Inc. | $10.30 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $83.34 | 1 | Boston Scientific Corporation ($83.34) |
| 2023 | $68.26 | 1 | GENZYME CORPORATION ($68.26) |
| 2022 | $224.17 | 2 | MML US, Inc. ($137.51) |
| 2021 | $69.50 | 1 | Relievant Medsystems, Inc. ($69.50) |
| 2020 | $70.48 | 2 | Boston Scientific Corporation ($66.67) |
| 2019 | $120.65 | 1 | GENZYME CORPORATION ($120.65) |
| 2018 | $270.73 | 3 | Augmenix, Inc. ($137.26) |
| 2017 | $215.51 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($105.21) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/09/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $83.34 | General |
| Category: General - Pain Management_NMD | ||||||
| 09/26/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $68.26 | General |
| 05/16/2022 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $137.51 | General |
| Category: Pain Management | ||||||
| 03/08/2022 | Relievant Medsystems, Inc. | Intracept (Device), Intracept | Food and Beverage | Cash or cash equivalent | $86.66 | General |
| Category: Pain | ||||||
| 04/29/2021 | Relievant Medsystems, Inc. | Intracept (Device), Intracept | Food and Beverage | Cash or cash equivalent | $69.50 | General |
| Category: Pain | ||||||
| 05/09/2020 | Merit Medical Systems Inc | StabiliT System (Device) | Food and Beverage | Cash or cash equivalent | $3.81 | General |
| Category: Radiology | ||||||
| 02/07/2020 | Boston Scientific Corporation | SUPERION (Device) | Food and Beverage | In-kind items and services | $66.67 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/29/2019 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $120.65 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 03/21/2018 | Janssen Scientific Affairs, LLC | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $95.69 | General |
| Category: Oncology | ||||||
| 03/01/2018 | Janssen Scientific Affairs, LLC | Erleada (Drug) | Food and Beverage | In-kind items and services | $37.78 | General |
| Category: Oncology | ||||||
| 02/08/2018 | Augmenix, Inc. | SpaceOAR (Device) | Food and Beverage | In-kind items and services | $137.26 | General |
| Category: Oncology | ||||||
| 12/07/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Oncology | ||||||
| 04/27/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $105.21 | General |
| 04/20/2017 | Medtronic Vascular, Inc. | Enteer (Device) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: Chronic Total Occlusion (CTO) Devices | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 86 | 8,089 | 250,090 | $7.8M | $879,136 |
| 2022 | 85 | 8,112 | 259,232 | $8.0M | $920,683 |
| 2021 | 49 | 4,634 | 148,040 | $5.0M | $587,115 |
| 2020 | 42 | 4,360 | 152,949 | $4.8M | $627,329 |
All Medicare Procedures & Services
262 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 1,050 | 1,110 | $2.7M | $246,269 | 9.3% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 561 | 578 | $688,486 | $84,604 | 12.3% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 423 | 426 | $538,132 | $52,144 | 9.7% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 122 | 123 | $227,668 | $32,276 | 14.2% |
| 70543 | Mri scan of bone of eye socket, face, and/or neck before and after contrast | Office | 2023 | 98 | 102 | $276,026 | $28,369 | 10.3% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 202 | 202 | $244,819 | $22,327 | 9.1% |
| 77067 | Screening mammography | Office | 2023 | 227 | 227 | $48,156 | $22,319 | 46.3% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 257 | 261 | $210,457 | $21,668 | 10.3% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 94 | 95 | $118,957 | $21,665 | 18.2% |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | Office | 2023 | 1,070 | 192,214 | $397,883 | $21,357 | 5.4% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 154 | 156 | $171,629 | $19,351 | 11.3% |
| 72156 | Mri scan of upper spinal canal before and after contrast | Office | 2023 | 109 | 110 | $205,358 | $19,020 | 9.3% |
| 74183 | Mri scan of abdomen before and after contrast | Office | 2023 | 58 | 59 | $164,092 | $14,843 | 9.0% |
| 72146 | Mri scan of middle spinal canal without contrast | Office | 2023 | 114 | 115 | $149,729 | $14,801 | 9.9% |
| 70544 | Mri scan of blood vessels of head without contrast | Office | 2023 | 91 | 92 | $120,023 | $14,508 | 12.1% |
| 72158 | Mri scan of lower spinal canal before and after contrast | Office | 2023 | 65 | 65 | $159,119 | $13,725 | 8.6% |
| 70486 | Ct scan of face without contrast | Office | 2023 | 139 | 140 | $69,211 | $13,709 | 19.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 137 | 137 | $43,822 | $12,720 | 29.0% |
| 70549 | Mri scan of blood vessels of neck before and after contrast | Office | 2023 | 46 | 46 | $110,642 | $12,503 | 11.3% |
| 70491 | Ct scan of soft tissue of neck with contrast | Office | 2023 | 87 | 88 | $85,347 | $12,446 | 14.6% |
| 70450 | Ct scan head or brain without contrast | Office | 2023 | 145 | 148 | $114,531 | $10,789 | 9.4% |
| 72157 | Mri scan of middle spinal canal before and after contrast | Office | 2023 | 57 | 57 | $101,770 | $10,279 | 10.1% |
| 70496 | Ct scan of blood vessels of head with contrast | Office | 2023 | 47 | 48 | $48,469 | $9,716 | 20.0% |
| 70480 | Ct scan of cranial cavity without contrast | Office | 2023 | 70 | 70 | $58,653 | $8,075 | 13.8% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 78 | 79 | $74,190 | $7,940 | 10.7% |
About Dr. Stuart Bobman, MD
Dr. Stuart Bobman, MD is a Diagnostic Radiology healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003853250.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Bobman, MD has received a total of $1,123 in payments from pharmaceutical and medical device companies, with $83.34 received in 2024. These payments were reported across 14 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,123).
As a Medicare-enrolled provider, Bobman has provided services to 25,195 Medicare beneficiaries, totaling 810,311 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 262 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Fort Myers, FL
- Active Since 05/31/2006
- Last Updated 01/03/2024
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1003853250
Products in Payments
- Intracept (Device) $156.16
- ReActiv8 (Device) $137.51
- SpaceOAR (Device) $137.26
- LEMTRADA (Drug) $120.65
- Xtandi (Drug) $100.00
- ZYTIGA (Drug) $95.69
- SUPERION (Device) $66.67
- Erleada (Drug) $37.78
- Enteer (Device) $10.30
- StabiliT System (Device) $3.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Fort Myers
Vladislav Maksimchuk, Do, DO
Diagnostic Radiology — Payments: $10,133
Mathieu Sabbagh, Do, DO
Diagnostic Radiology — Payments: $6,198
Craig Reiheld, M.d, M.D
Diagnostic Radiology — Payments: $5,832
Dr. Thomas Presbrey, Md, MD
Diagnostic Radiology — Payments: $4,917
Edward Danehy, Md, MD
Diagnostic Radiology — Payments: $3,969
Dr. Elsio Negron-Rubio, M.d, M.D
Diagnostic Radiology — Payments: $3,685